About Limulus Bio
Limulus Bio is a Healthcare company based in Stockholm (Sweden) founded in 2020, and was acquired by Veranex in October 2022. Provider of risk assessment and biological evaluation consulting services for devices manufacturers. Its chief executive, as recorded, is Elisabeth Liljensten. Its focus areas include Medical Device Outsourcing.
Company details
Limulus Bio was founded in 2020 and is based in Stockholm, Sweden. Operations focus on the medical device sector, where risk assessment, biological evaluation, and consulting services are delivered to manufacturers. These services support compliance and safety evaluations for medical devices. The company is led by CEO Elisabeth Liljensten, with expertise centered on regulatory and biological aspects of device development.
- Headquarters Stockholm, Sweden
- Stage Acquired
- SectorsHealthcare
- Website limulusbio.com
- Social LinkedIn
- Acquired by Veranex (Oct 2022)
Investors in Limulus Bio
Limulus Bio has secured backing from 1 investor. Prominent investors backing the company include Veranex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Veranex is recognized as an Innovation CRO specializing in medical device and diagnostic development. | veranexsolutions.com | Raleigh, United States |
Investor details for Limulus Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Limulus Bio
1 people are tracked at Limulus Bio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Elisabeth Liljensten | CEO | Leadership |
Complete people profiles for Limulus Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Limulus Bio
2 dated milestones of Limulus Bio across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Limulus Bio is founded.
- Exit Acquired by Veranex.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Limulus Bio
Limulus Bio was founded in 2020.
Limulus Bio is headquartered in Stockholm, Sweden.
Elisabeth Liljensten is the CEO of Limulus Bio, as recorded in our data.
Limulus Bio was founded in 2020 and is based in Stockholm, Sweden. Operations focus on the medical device sector, where risk assessment, biological evaluation, and consulting services are delivered to manufacturers. These services support compliance and safety evaluations for medical devices. The company is led by CEO Elisabeth Liljensten, with expertise centered on regulatory and biological aspects of device development.
Limulus Bio has 1 investor. Key investors include Veranex.
Yes. Limulus Bio was acquired by Veranex in October 2022.